NewsRx

Search our medical news database

SuperGen Inc.

SuperGen Names Mohammad Azab, M.D., Chief Medical Officer

Published in Cancer Weekly, August 4th, 2009

SuperGen Inc. (Nasdaq:SUPG) announced the addition of Mohammad Azab, M.D., M Sc, MBA to the management team as Chief Medical Officer. Dr. Azab will manage SuperGen's clinical development strategy, clinical operations, regulatory affairs, quality, and safety departments to advance the Company's oncology product portfolio from discovery through clinical Proof of Concept. His responsibilities will include the design and execution of clinical trials, including the recently commenced Phase I study of the first-in-class PIM Kinase Inhibitor, SGI-1776.

With more than 20 years of experience in worldwide drug development, clinical research, and medical affairs, resulting in...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook